ArticleFoods (Basel, Switzerland)2026
Prioritizing Artificial Intelligence Opportunities for Food as Health in the U.S. Agrifood Value Chain.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Food and health are converging across the agrifood value chain, and artificial intelligence (AI) is widely promoted to operationalize the link, yet firms cannot tell which food-as-health opportunities current AI can address. We identify the agrifood industry's highest-priority food-as-health opportunities in the United States and assess, against the peer-reviewed AI literature, how far current AI can address each. A PRISMA 2020 systematic review of 34 U.S.-focused studies establishes the problem space; a Jobs-to-Be-Done map organizes ninety opportunity areas; a blind discovery forum with 37 senior U.S. practitioners gives an independent reading; a convergence analysis joins the map and the forum; and a separate assessment grades each opportunity against the AI literature. Practitioner priorities converge on twelve opportunities in the two segments that physically determine food's health attributes, agricultural production and food manufacturing. These resolve into five AI capability families. The evidence is strong for sensing, traceability, design, and personalization, and more qualified for evidence synthesis and regulatory intelligence, where reliability limits require human oversight. One core need lies beyond AI, a preliminary finding of a symmetric long-term-contract gap that appears relational. We grade an agenda by how far current AI reaches, with an explicit boundary on what it cannot address.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.